Skip to content

News Category: Health & Medical

Ready to Enter the Middle East Market, Vazyme Showcases Its COVID-19 Testing Solutions at Medlab Middle East 2022

By asianet

Leading China-based biotech company Vazyme (688105.SH) participated in the 2022 edition of Medlab Middle East in the Dubai World Trade Centre (DWTC) from January 24th to 27th, a leading laboratory and flagship exhibition and conference that brings together global medical communities to display the best laboratory innovation and technology. At Booth No. Z5.H20, the company … Continued

Enable Injections Announces $215 Million Financing

By asianet

–New financing provides significant financial flexibility to propel growth efforts, benefitting patients, providers, and pharma partners worldwide. Enable Injections, Inc. ( https://enableinjections.com ) (“Enable”), a company developing and manufacturing the enFuse(R) platform of investigational wearable drug delivery systems, is pleased to announce $215 million in Series C financing. Magnetar Capital (“Magnetar”) led the financing along … Continued

Lifebit partners with NIHR Cambridge Biomedical Research Centre to launch the CYNAPSE platform for next-generation genomics research

By asianet

Lifebit today announces a long-term partnership where Lifebit’s technology, Lifebit CloudOS, will power a cloud-based Trusted Research Environment (TRE) to serve as the scalable and secure data management and analysis platform for researchers at the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre (BRC). Photo – https://mma.prnewswire.com/media/1732901/Lifebit.jpg As one of the leading UK … Continued

IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly

By asianet

Concept Medical Inc., [https://www.conceptmedical.com/] focused on vascular intervention drug delivery devices, shares the latest status of its IMPRESSION (sIroliMus coated balloon angioPlasty versus plain balloon angioplasty in the tREatment of dialySis acceSs dysfunctION) randomized controlled trial (RCT), as it crosses the 50 per cent enrollment mark. IMPRESSION randomized trial enrolled its index patient on January … Continued

Applied Pharmaceutical Science Inc. Announces FDA Approval of Investigational New Drug Application for APS03118, a Next generation RET Original New Drug for Unlimited Cancers

By asianet

Applied Pharmaceutical Science, Inc. (“APS” or “the Company”), has recently announced the Investigational New Drug (IND) application for its self-developed breakthrough new drug APS03118, a next generation selective RET inhibitor, has been approved by the U.S. Food and Drug Administration (FDA). The clinical application is also in the process of being submitted to the National … Continued

Hinova Announces First Patient Dosed in a Phase I Clinical Trial of HP518, an orally bioavailable Chimeric Degrader targeting Androgen Receptor for Prostate Cancer Treatment

By asianet

Hinova Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on developing novel therapeutics for cancers and metabolic diseases through targeted protein degradation technologies, announced that the first patient with metastatic castration-resistant prostate cancer (mCRPC) has been successfully dosed in a Phase I clinical trial of HP518, a highly selective and orally bioavailable chimeric degrader targeting androgen … Continued

Victor Papamoniodis Joins Medison Pharma as VP International Markets

By asianet

Medison [https://www.medisonpharma.com], a global pharma company focused on providing access to highly innovative therapies to patients in international markets (“Medison”), is proud to announce the joining of Victor Papamoniodis in the newly created position of VP International Markets. Victor will be based in Zug, Switzerland, Medison’s international headquarters. Victor will head Medison’s markets outside of … Continued

Sputnik V demonstrates strong protection against Omicron variant, with over 2 times higher virus neutralizing activity compared to the Pfizer vaccine according to a unique independent comparative study conducted by the Spallanzani Institute in Italy

By asianet

Previous studies also demonstrated additional significant strengthening of protection against Omicron by Sputnik Light booster, which can also be a universal booster to other vaccines to strengthen and lengthen their protection against Omicron. – A unique comparative study conducted at the Italian Spallanzani Institute, the leading Italian research institute for infectious diseases, by a joint … Continued

Successful Completion of First Patient Implantation of MINI WELL(R)and MINI WELL TORIC(R) Extended Depth-of-Focus IOLs in China Announced by Affamed Technologies, Joint Venture between AffaMed Therapeutics and SIFI

By asianet

SIFI, a leading international ophthalmic company headquartered in Italy, is pleased to divulge the successful completion of the first patient implantation of MINI WELL(R) and MINI WELL TORIC(R) IOLs in China, announced via Affamed Technologies, Joint Venture between AffaMed Therapeutics and SIFI. MINI WELL(R)and MINI WELL TORIC(R) IOLs were successfully implanted following phacoemulsification cataract surgical … Continued